Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.43
|
1.65
|
1.55
|
1.4016
|
1.55
|
1.46
|
|
|
66 043.86
|
268.00
|
1.45
|
1.52
|
1.47
|
1.43
|
1.49
|
1.45
|
|
|
66 827.08
|
290.00
|
1.43
|
1.50
|
1.43
|
1.43
|
1.5243
|
1.48
|
|
|
77 091.82
|
267.00
|
1.41
|
1.53
|
1.49
|
1.40
|
1.54
|
1.43
|
|
|
82 629.19
|
297.00
|
1.48
|
1.54
|
1.60
|
1.49
|
1.60
|
1.49
|
|
|
103 708.13
|
377.00
|
1.53
|
1.57
|
1.58
|
1.51
|
1.63
|
1.53
|
|
|
111 795.57
|
401.00
|
1.53
|
1.61
|
1.52
|
1.4825
|
1.65
|
1.57
|
|
|
225 235.34
|
|
1.46
|
1.60
|
1.55
|
1.44
|
1.62
|
1.47
|
|
|
173 735.98
|
502.00
|
1.55
|
1.62
|
1.55
|
1.54
|
1.67
|
1.58
|
|
|
182 803.02
|
492.00
|
1.48
|
1.58
|
1.50
|
1.49
|
1.5998
|
1.58
|
|
|
223 509.24
|
584.00
|
TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.